On the other hand, we did not find evidence for the superiority of NM (a synthetic serine protease inhibitor with a short half‐life) or anticoagulants primarily by inhibiting factor Xa (LMWH) in post‐ES bleeding prevention in HD patients. This evidence concerns the gene TNXA and Huntington disease.